Summary

The product Mentolad (50 mg/ml), manufactured by Driada Medical, underwent analysis to verify its content and potency. The sample, identified by batch number 971254, was tested by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Trestolone Acetate, with a measured concentration of 51.67 mg/ml, slightly exceeding the label claim of 50 mg/ml by 3.34%. These findings suggest the product is accurately dosed and aligns closely with its specification.

The testing process was initiated on 13 December 2021, the sample was received on 14 December 2021, and the analysis was completed on 16 December 2021. The sample was submitted and funded by Driada Medical, warranting careful scrutiny of the results. The sample underwent retesting twice for verification, adding confidence to the accuracy of the findings. This report serves as a resource for educational and harm reduction purposes, enabling users to make informed decisions about the quality and reliability of anabolic steroid products.

Detailed Report

Product Overview

• Manufacturer: Driada Medical
• Product Name: Mentolad (50 mg/ml)
• Active Ingredient: Trestolone Acetate
• Batch Number: 971254
• Expiration Date: Not provided
• Delivery Method: Injectable

Sample Acquisition and Testing

• Task Number: #15083
• Testing Ordered: 13 December 2021
• Sample Received: 14 December 2021
• Analysis Conducted By: Janoshik Analytical
• Product Submitted By: Driada Medical
• Analysis Paid For By: Driada Medical

Testing Results

• Specification: 50 mg/ml (as stated on the label)
• Measured Concentration: 51.67 mg/ml
• Accuracy: 103.34% (3.34% above the label claim)

Verification Details

• Verification URL:
  https://janoshik.com/tests/15083_46DANSEJICBC
• Originally Published:
  https://thinksteroids.com/community/posts/2910574/

Evaluation of Manufacturer-Funded Testing

As this test was submitted and paid for by the manufacturer, Driada Medical, the findings warrant careful consideration. Manufacturer-funded testing raises potential concerns such as selective testing of optimal batches or conflicts of interest. However, the lab conducting the analysis, Janoshik Analytical, is recognized for its transparency and reliable history in pharmaceutical testing. The retesting of the sample further supports the validity of the results.

While the product appears to meet its labeled specifications, third-party, independent testing would provide further validation, enhancing consumer confidence.

Conclusion

This analysis highlights the importance of lab testing for ensuring the quality and reliability of anabolic steroid products. The results demonstrate that Mentolad (50 mg/ml) by Driada Medical is accurately dosed, slightly exceeding the label claim. Such testing provides valuable insights for harm reduction and educational purposes, assisting individuals in making informed, safer decisions.

Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.